At close: June 28 at 6:07:38 PM EDT ...
By Anita Dushyanth, PhD NASDAQ:CYNA There have been several events since our last update including progress on Phase 3 efficacy study, addition to the board of directors and presentation of clinical ...
Cynapsus Therapeutics Inc (CYNA) agreed to be acquired in a $624 million all-cash deal Canadian pharmaceutical stock Cynapsus Therapeutics Inc (NASDAQ:CYNA) is the Nasdaq's top performer by a mile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results